This verification of Compendial methods webinar training will discuss the requirements of USP <1226>, what are FDA expectations related to method verification.
This webinar will provide an in-depth discussion of USP <1226>, `Verification of Compendial Methods` requirements. FDA 483s on the subject of Method Verification will be discussed to understand current FDA expectations. Conditions under which Methods can be classified as `basic` and not require verification will be discussed. The factors under actual conditions of use which impact method performance and make method verification necessary will be addressed. FDA 483s on the subject of Method Verification will be discussed to understand current FDA expectations on which compendial methods needs to be verified.
Areas Covered in the Seminar: - FDA 483s related to method verification.
- Requirements of USP <1226>, `Verification of Compendial Methods`.
- What are the current FDA expectations related to method verification.
- FDA 483s related to method verification.
- Requirements of USP <1226>, `Verification of Compendial Methods`.
- What are the factors which impact method performance under actual condition of use?
- How compliance to USP <1226> and investment risk.
Who Will Benefit:This course is intended to provide training on how to evaluate compendial methods in order to comply with USP <1226>
- QC personnel
- QC Supervisors and Management
- QA personnel
- QA Management
- Documentation management specialists
- Regulatory affairs personnel
- R&D Lab personnel
- R&D Lab Supervisors
